+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Secondary Progressive Multiple Sclerosis (SPMS) - Disease Overview and Epidemiology

  • ID: 4431977
  • Report
  • October 2017
  • Region: Global, Global
  • Pharma Scroll
1 of 2

This report provides an overview of secondary progressive multiple sclerosis (SPMS) disease indication in detail and highlights the SPMS epidemiology in the current scenario and includes future forecasts and covers key geographies across the globe. The report starts with a basic definition, causes and symptoms of Multiple Sclerosis (MS) and further details the types of Multiple Sclerosis disease indication. The report elaborates on the Secondary Progressive Multiple Sclerosis disease indication starting from the definition and the causes of the SPMS indication.

In addition, the report covers further details on the profile of a SPMS patient, the symptoms of a SPMS patient, and disease progression in a SPMS patient. The report further highlights the multiple methods through which the patient can be diagnosed for SPMS. The latter part of the report consists of SPMS epidemiology and prevalence in key geographies across the globe such as the US, the UK, Germany, Italy, France, Spain and Japan. The epidemiology for SPMS indication across key geographies has been forecasted up to 2024.

Note: Product cover images may vary from those shown
2 of 2

1. Multiple Sclerosis Definition

2. Types of Multiple Sclerosis

a. Relapsing Remitting MS

b. Secondary Progressive MS

c. Primary Progressive MS

d. Progressive Relapsing MS

3. Secondary Progressive Relapsing MS Defined

4. Causes of SPMS

5. Profile of SPMS Patient

6. Symptoms of SPMS

7. Disease progression and impact on QoL

8. Disease Diagnosis

a. Disease diagnosis through symptoms

b. Disease diagnosis through medical tests

9. Disease Epidemiology

a. US Epidemiology

b. UK Epidemiology

c. Germany Epidemiology

d. Italy Epidemiology

e. France Epidemiology

f. Spain Epidemiology

g. Japan Epidemiology

Note: Product cover images may vary from those shown
3 of 2